Longevity

January 10, 2018

Lifespan extension therapy:  Candesartan, an angiotensin II receptor antagonist used mainly in the treatment of hypertension, may increase life span via up-regulation of its target gene BubR1, 10/January/2017, 7.02 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
January 10, 2018

Lifespan extension therapy: Atorvastatin (Trade name: Lipitor), a lipid-lowering agent, prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 10/January/2017, 6.38 pm,

Significance of the study: It has been shown earlier that antagonizing angiotensin II type I receptor (AT1R) expression may prolong mammalian life span. Further, it has been shown […]
January 9, 2018

Life-extension therapy: Tomatidine, isolated from unripe tomoto, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 9/January/2017, 11.59 pm

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal […]
January 9, 2018

Lifespan extension therapy:  Telmisartan [Brand name: Micardis], an anit-hypertensive medication, increases life span via up-regulation of its target gene BubR1, 9/January/2017, 11.47 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]